Carotid revascularization and medical management for asymptomatic carotid stenosis - Hemodynamics (CREST-H): Study design and rationale.

Int J Stroke 2018 12 22;13(9):985-991. Epub 2018 Aug 22.

8 Department of Neurology, Mayo Clinic, Jacksonville, USA.

Rationale: For patients with asymptomatic high-grade carotid stenosis, clinical investigations have focused on preventing cerebral infarction, yet stenosis that reduces cerebral blood flow may independently impair cognition. Whether revascularization of a hemodynamically significant carotid stenosis can alter the course of cognitive decline has never been investigated in the context of a randomized clinical trial.

Hypothesis: Among patients randomized in the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis (CREST-2) trials, the magnitude of treatment differences (revascularization versus medical management alone) with regard to cognition will differ between those with flow impairment compared to those without flow impairment.

Sample Size: We will enroll approximately 500 patients from CREST-2, of which we anticipate 100 will have hemodynamic impairment. We estimate 93% power to detect a clinically meaningful treatment difference of 0.5 SD.

Methods And Design: We will use perfusion-weighted magnetic resonance imaging to stratify by hemodynamic status. Linear regression will compare treatment differences, controlling for baseline cognitive status, age, depression, prior cerebral infarcts, silent infarction, white matter hyperintensity volume, and cerebral microbleeds.

Study Outcomes: The primary outcome is change in cognition at one year. Secondary outcomes include silent infarction, change in white matter hyperintensity volume, number of cerebral microbleeds, and cortical thickness over one year.

Discussion: If cognitive impairment can be shown to be reversible by revascularization, then we can redefine "symptomatic carotid stenosis" to include cognitive impairment and identify a new population of patients likely to benefit from revascularization.

Trial Registration: US National Institutes of Health (NIH) clinicaltrials.gov NCT03121209.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1747493018790088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384010PMC
December 2018
40 Reads

Publication Analysis

Top Keywords

carotid stenosis
16
medical management
12
cognitive impairment
8
matter hyperintensity
8
white matter
8
treatment differences
8
silent infarction
8
asymptomatic carotid
8
hyperintensity volume
8
revascularization medical
8
carotid revascularization
8
management asymptomatic
8
carotid
7
cerebral
5
stenosis
5
will
5
imaging stratify
4
stratify hemodynamic
4
magnetic resonance
4
design will
4

References

(Supplied by CrossRef)

Pendlebury ST et al.
Lancet Neurol 2009

Hachinski V et al.
Stroke 2008

Gorelick PB et al.
Stroke 2011

Tatemichi TK et al.
J Neurol Neurosurg Psychiatry 1995

Silvestrini M et al.
Neurology 2009

Buratti L et al.
Stroke 2014

Marshall RS et al.
Neurology 2012

de la Torre JC et al.
Brain Res 1993

Balestrini S et al.
Neurology 2013

Marshall RS et al.
PLoS One 2017

Lal BK et al.
J Vasc Surg 2011

Similar Publications